| Name | 1-butylpiperazine-2,3-dione |
|---|---|
| Synonyms |
1-Butyl-2,3-piperazinedione
4-Butyl-2,3-piperazinedione 1-Butyl-2.3-dioxo-piperazin 1-butyl-piperazine-2,3-dione 4-Butyl-2,3-dioxopiperazine 2,3-Piperazinedione,1-butyl |
| Density | 1.083g/cm3 |
|---|---|
| Molecular Formula | C8H14N2O2 |
| Molecular Weight | 170.20900 |
| Exact Mass | 170.10600 |
| PSA | 49.41000 |
| LogP | 0.01160 |
| Index of Refraction | 1.474 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2933599090 |
|---|
|
~45%
2385-28-6 |
| Literature: MERCK and CO., INC. Patent: WO2008/36316 A2, 2008 ; Location in patent: Page/Page column 42 ; WO 2008/036316 A2 |
|
~%
2385-28-6 |
| Literature: SUNESIS PHARMACEUTICALS, INC. Patent: WO2003/106405 A1, 2003 ; Location in patent: Page 226-230 ; WO 03/106405 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |